Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
View ORCID ProfileJavier Perez-Saez, View ORCID ProfileMaría-Eugenia Zaballa, View ORCID ProfileJulien Lamour, View ORCID ProfileSabine Yerly, Richard Dubos, View ORCID ProfileDelphine Courvoisier, View ORCID ProfileJennifer Villers, Jean-François Balavoine, View ORCID ProfileDidier Pittet, View ORCID ProfileOmar Kherad, Nicolas Vuilleumier, View ORCID ProfileLaurent Kaiser, Idris Guessous, View ORCID ProfileSilvia Stringhini, View ORCID ProfileAndrew S. Azman the Specchio-COVID19 study group
doi: https://doi.org/10.1101/2022.12.13.22283400
Javier Perez-Saez
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
María-Eugenia Zaballa
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
Julien Lamour
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
Sabine Yerly
3Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland
Richard Dubos
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
Delphine Courvoisier
4General Directorate of Health, Geneva, Switzerland
Jennifer Villers
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
Jean-François Balavoine
5Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Didier Pittet
5Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
6Infection Control Program and World Health Organization Collaborating Centre on Patient Safety, Geneva University Hospitals, Geneva, Switzerland
Omar Kherad
5Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
7Division of Internal Medicine, Hôpital de la Tour, Geneva, Switzerland
Nicolas Vuilleumier
3Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland
5Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Laurent Kaiser
3Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland
5Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
8Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland
9Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
Idris Guessous
10Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
11Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
Silvia Stringhini
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
12University Centre for General Medicine and Public Health, University of Lausanne, Lausanne, Switzerland
Andrew S. Azman
1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
Data Availability
Data produced in this study is accessible to researchers upon reasonable request.
Posted December 15, 2022.
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
Javier Perez-Saez, María-Eugenia Zaballa, Julien Lamour, Sabine Yerly, Richard Dubos, Delphine Courvoisier, Jennifer Villers, Jean-François Balavoine, Didier Pittet, Omar Kherad, Nicolas Vuilleumier, Laurent Kaiser, Idris Guessous, Silvia Stringhini, Andrew S. Azman
medRxiv 2022.12.13.22283400; doi: https://doi.org/10.1101/2022.12.13.22283400
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
Javier Perez-Saez, María-Eugenia Zaballa, Julien Lamour, Sabine Yerly, Richard Dubos, Delphine Courvoisier, Jennifer Villers, Jean-François Balavoine, Didier Pittet, Omar Kherad, Nicolas Vuilleumier, Laurent Kaiser, Idris Guessous, Silvia Stringhini, Andrew S. Azman
medRxiv 2022.12.13.22283400; doi: https://doi.org/10.1101/2022.12.13.22283400
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)